-
August 09, 2012
Teva Pharmaceutical Industries Ltd. (TEVA) and Active Biotech recently announced that they intend to commence a ...
-
August 09, 2012
Isis Pharmaceuticals Inc. (ISIS) reported a net loss of 1 cent per share in the second quarter of 2012, well below ...
-
August 06, 2012
Alnylam Pharmaceuticals Inc. (ALNY) recently earned development milestone payment of $3.2 million from ...
-
August 06, 2012
PDL BioPharma Inc. (PDLI) posted second-quarter earnings of 53 cents per share, above the year-ago figure of 39 ...
-
August 02, 2012
Biogen Idec's (BIIB) second quarter EPS of $1.82 was well above the Zacks Consensus Estimate of $1.56 and the ...
-
August 01, 2012
Acorda Therapeutics Inc. (ACOR) reported second quarter earnings (including share-based compensation charges but ...
-
July 26, 2012
The Medicines Company (MDCO) reported second quarter earnings of 25 cents per share. Second quarter earnings were ...
-
July 24, 2012
Biogen Idec (BIIB) reported second quarter earnings per share of $1.82, well above the Zacks Consensus Estimate of ...
-
July 24, 2012
Biogen Idec (Nasdaq:BIIB) announced its results for the most recent quarter on July 24, 2012. Biogen Idec is a ...
-
July 23, 2012
Biogen Idec Inc. (BIIB) is slated to announce its second quarter results on Tuesday, July 24, before the opening ...
-
July 20, 2012
Swiss pharmaceutical giant Novartis (NVS) reported second quarter 2012 earnings per share of $1.12, down 1% from the ...
-
July 20, 2012
When Biogen Idec (Nasdaq:BIIB) releases its second quarter earnings on Tuesday, July 24, 2012, it is expected to ...
-
July 18, 2012
Abbott Labs (ABT) reported second quarter earnings of $1.23 per share, a couple of cents above the Zacks Consensus ...
-
July 11, 2012
We recently reiterated our Neutral recommendation on Isis Pharmaceuticals (ISIS), which carries a Zacks #3 Rank ...
-
July 06, 2012
Biogen Idec (BIIB) and partner Swedish Orphan Biovitrum recently announced that they are evaluating their hemophilia ...
-
July 02, 2012
Isis Pharmaceuticals, Inc. (ISIS) and Biogen Idec (BIIB) have teamed up again. This time round the companies are ...
-
June 15, 2012
Novartis AG (NVS) recently announced new long-term data from an extended phase III head-to-head TRANSFORMS study, ...
-
June 14, 2012
Acorda Therapeutics, Inc. (ACOR) recently announced the enrollment of the first patient in a proof-of-concept study ...
-
June 14, 2012
PDL BioPharma Inc. (PDLI) recently announced that it expects to generate second-quarter 2012 royalty revenues of ...
-
June 08, 2012
Dr. Reddy's Laboratories Ltd. (RDY) recently announced a collaboration agreement with Merck Serono, a division of ...
